Amgen Makes Repatha® Available Through AmgenNow, A Direct-to-patient Program in the US
THOUSAND OAKS, Calif., Oct. 6, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch...
Read More...REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C
THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food...
Read More...National Lipid Association Releases New Guidance: "LDL Cholesterol Management Simplified in Adults – Lower for Longer is Better"
The National Lipid Association (NLA) today announced the release of a major new clinical guidance document titled "LDL...
Read More...Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care: A National Lipid Association Expert Clinical Review
This Expert Clinical Review highlights the importance of a collaborative approach to the management of dyslipidemia and...
Read More...NLA and FNLA Urge CMS and Administrator Oz to Include Low-Density Lipoprotein Cholesterol (LDL-C) Measurement in CMS Quality Measurement Programs
The National Lipid Association (NLA) and Foundation of the National Lipid Association (Foundation) urge the Centers for...
Read More...The National Lipid Association (NLA) today announced the release of a major new clinical guidance document titled "LDL...
This Expert Clinical Review highlights the importance of a collaborative approach to the management of dyslipidemia and...
Familial Chylomicronemia Syndrome: An Expert Clinical Review from the National Lipid Association
The National Lipid Association (NLA) has released a comprehensive clinical review titled "Familial Chylomicronemia...
The risk of atherosclerotic cardiovascular disease increases with advancing age.
Extreme hypertriglyceridemia, defined as triglyceride (TG) levels ≥1000 mg/dL, is almost always indicative of...